Elekta’s Nomination Committee proposal for the election of Board of Directors and Auditors to the Annual General Meeting 2012
Stockholm, Sweden, June 18, 2012
The Nomination Committee of Elekta AB (publ) proposes the following to the company’s Annual General Meeting on September 4, 2012.
The Nomination Committee of Elekta AB (publ) proposes that the Board of Directors consists of eight members. The Nomination Committee proposes the re-election of Akbar Seddigh, Hans Barella, Luciano Cattani, Laurent Leksell, Siaou-Sze Lien, Wolfgang Reim, Jan Secher and Birgitta Stymne Göransson as members of the Board. Furthermore, the Nomination Committee also proposes that Akbar Seddigh is re-appointed Chairman of the Board.
The Nomination Committee proposes that PwC is elected as the Company’s auditor, with Authorized Public Accountant Johan Engstam as auditor in charge.
The complete proposal of the Nomination Committee for resolution at the Annual General Meeting on September 4, 2012 will be presented in the notice of the Annual General Meeting.
The Nomination Committee consists of Laurent Leksell (Chairman), private and companies’ holdings; Åsa Nisell, Swedbank Robur funds, Anna Ohlsson-Leijon, SEB Funds; Ingrid Bonde, AMF Insurance and Funds; and Akbar Seddigh, Chairman of the Board.
For further information, please contact:
Johan Andersson Melbi, Investor Relations Manager, Elekta AB
Tel: +46 702 100 451, email: firstname.lastname@example.org
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on June 18, 2012.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.